Federal Controlled Substances Act: Controlled Substances Prescriptions

Cannabis and the U.S. Controlled Substances Act

The scheduling of cannabis under the Controlled Substances Act (CSA) has established legal precedents that determine how scientific evidence affects its regulation in the United States. This background challenges three common fallacies that make it seem marijuana prohibition is the only viable policy outcome. A contemporary effort to reschedule cannabis is based on recent findings that have est...

The Federal Hazardous Substances Labeling Act.

BOUT 10 years ago when the Committee on Accident Prevention was created, the Academy focused national attention on accidents as the No. 1 cause of death in childhood and a major contributor to disability, disfigurement and crippling. One of the most spectacular features of this Committee’s program is its efforts to prevent and treat poisoning in children, as demonstrated by the amazing growth o...

Dispensing controlled substances for the treatment of pain issuance of multiple prescriptions for schedule II controlled substances.

On January 18, 2005, DEA published in the Federal Register a solicitation of comments on the subject of dispensing controlled substances for the treatment of pain. Many of the comments that DEA received asked the agency to elaborate on the legal requirements and agency policy relating to this subject. This document provides such information.

Guidelines for prescribing of controlled substances.

This clinical policy deals with critical issues in prescribin of opioids for adult patients treated in the emergency department (ED). This guideline is the result of the efforts the American College of Emergency Physicians, in consultation with the Centers for Disease Control and Prevention, and the Food and Drug Administration. The critical questions addressed in this clinical policy are: (1) ...

Nurse practitioners and prescribing controlled substances.